IPPB-assisted coughing in neuromuscular disorders

In neuromuscular disorders, reduced peak cough flows (PCFs) are considered to increase the risk of respiratory complications such as pneumonia or chronic atelectasis. Different methods were described to improve PCF. However, these studies were primarily carried out in adults, and there is limited in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric pulmonology 2006-06, Vol.41 (6), p.551-557
Hauptverfasser: Dohna-Schwake, Christian, Ragette, Regine, Teschler, Helmut, Voit, Thomas, Mellies, Uwe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 557
container_issue 6
container_start_page 551
container_title Pediatric pulmonology
container_volume 41
creator Dohna-Schwake, Christian
Ragette, Regine
Teschler, Helmut
Voit, Thomas
Mellies, Uwe
description In neuromuscular disorders, reduced peak cough flows (PCFs) are considered to increase the risk of respiratory complications such as pneumonia or chronic atelectasis. Different methods were described to improve PCF. However, these studies were primarily carried out in adults, and there is limited information regarding the use and efficacy of these methods in children with respiratory muscle weakness. The aim of this study was to investigate whether hyperinsufflation with an intermittent positive‐pressure breathing (IPPB) device is effective in cough augmentation in pediatric patients. Spirometry (forced inspiratory vital capacity, FIVC; forced expiratory volume in 1 sec, FEV1), respiratory muscle pressures (peak inspiratory pressure, PIP; peak expiratory pressure, PEP), and PCF were measured in 29 schoolchildren with various neuromuscular disorders. IPPB‐assisted hyperinsufflation was taught individually to increase lung volumes (maximum insufflation capacity, MIC) above FIVC. The impact of hyperinsufflation on peak cough flow was documented. In 28/29 patients, IPPB‐assisted hyperinsufflation enhanced FIVC from 0.68 ± 0.40 l to an MIC of 1.05 ± 0.47 l (P 
doi_str_mv 10.1002/ppul.20406
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67924299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67924299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4616-edd4fee90e23d22c0d5cf624fad6b66f183336e445be738fd2810a026a14e6773</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EgvKx8ANQFxiQAj7bOScjRVBAFVQCxGi59gUCaVJsIuDfk9ICG9MN97zv6R7GdoEfAefieDZrqyPBFccV1gOe5wlXOa6yXqbTNMEM5QbbjPGZ826XwzrbAETQKoUeg8vxeJDYGMv4Rr7vmvbxqawf-2Xdr6kNzbSNrq1s6PsyNsFTiNtsrbBVpJ3l3GL352d3pxfJ6GZ4eXoySpxCwIS8VwVRzklIL4TjPnUFClVYjxPEAjIpJZJS6YS0zAovMuCWC7SgCLWWW-xg0TsLzWtL8c1My-ioqmxNTRsN6lwokecdeLgAXWhiDFSYWSinNnwa4GYuyMwFmW9BHby3bG0nU_J_6NJIB-wvARudrYpga1fGP05noAHnHCy497Kiz39OmvH4fvRzPFlk5rI_fjM2vHTfSJ2ah-uh4VfiDmFwa4byCxzBi-E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67924299</pqid></control><display><type>article</type><title>IPPB-assisted coughing in neuromuscular disorders</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Dohna-Schwake, Christian ; Ragette, Regine ; Teschler, Helmut ; Voit, Thomas ; Mellies, Uwe</creator><creatorcontrib>Dohna-Schwake, Christian ; Ragette, Regine ; Teschler, Helmut ; Voit, Thomas ; Mellies, Uwe</creatorcontrib><description>In neuromuscular disorders, reduced peak cough flows (PCFs) are considered to increase the risk of respiratory complications such as pneumonia or chronic atelectasis. Different methods were described to improve PCF. However, these studies were primarily carried out in adults, and there is limited information regarding the use and efficacy of these methods in children with respiratory muscle weakness. The aim of this study was to investigate whether hyperinsufflation with an intermittent positive‐pressure breathing (IPPB) device is effective in cough augmentation in pediatric patients. Spirometry (forced inspiratory vital capacity, FIVC; forced expiratory volume in 1 sec, FEV1), respiratory muscle pressures (peak inspiratory pressure, PIP; peak expiratory pressure, PEP), and PCF were measured in 29 schoolchildren with various neuromuscular disorders. IPPB‐assisted hyperinsufflation was taught individually to increase lung volumes (maximum insufflation capacity, MIC) above FIVC. The impact of hyperinsufflation on peak cough flow was documented. In 28/29 patients, IPPB‐assisted hyperinsufflation enhanced FIVC from 0.68 ± 0.40 l to an MIC of 1.05 ± 0.47 l (P &lt; 0.001). Unassisted PCF was 119.0 ± 57.7 l/min, and increased to 194.5 ± 74.9 l/min (P &lt; 0.001) in 27/29 patients. This effect was similar in young patients (ages 6–10 years) and older patients (aged &gt;10 years). Augmentation of lung volumes from FIVC to MIC correlated with an increase of PCF (R = 0.42, P &lt; 0.05). IPPB‐assisted hyperinsufflation improves PCF in pediatric neuromuscular disorders. The results suggest that this technique can be used to improve clearance of airway secretions and therefore reduce respiratory morbidity in children with NMD. Pediatr Pulmonol. © 2006 Wiley‐Liss, Inc.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.20406</identifier><identifier>PMID: 16617451</identifier><identifier>CODEN: PEPUES</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; Age Factors ; assisted coughing ; Biological and medical sciences ; Child ; Cough - etiology ; Cough - therapy ; Female ; Forced Expiratory Volume - physiology ; Humans ; Intermittent Positive-Pressure Breathing - methods ; Male ; maximum insufflation capacity ; Medical sciences ; Muscle Weakness - physiopathology ; Muscular Atrophy, Spinal - complications ; Muscular Atrophy, Spinal - physiopathology ; Muscular Dystrophies - complications ; Muscular Dystrophies - congenital ; Muscular Dystrophies - physiopathology ; Muscular Dystrophy, Duchenne - complications ; Muscular Dystrophy, Duchenne - physiopathology ; Neuromuscular Diseases - complications ; Neuromuscular Diseases - physiopathology ; neuromuscular disorders ; peak cough flow ; Pneumology ; Pulmonary Ventilation - physiology ; Respiration Disorders - etiology ; Respiration Disorders - therapy ; Respiratory Function Tests ; respiratory muscle weakness ; Respiratory Muscles - physiopathology ; Respiratory system : syndromes and miscellaneous diseases ; Respiratory Therapy - instrumentation ; Respiratory Therapy - methods ; Spirometry ; Treatment Outcome ; Vital Capacity - physiology</subject><ispartof>Pediatric pulmonology, 2006-06, Vol.41 (6), p.551-557</ispartof><rights>Copyright © 2006 Wiley‐Liss, Inc.</rights><rights>2006 INIST-CNRS</rights><rights>Copyright 2006 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4616-edd4fee90e23d22c0d5cf624fad6b66f183336e445be738fd2810a026a14e6773</citedby><cites>FETCH-LOGICAL-c4616-edd4fee90e23d22c0d5cf624fad6b66f183336e445be738fd2810a026a14e6773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fppul.20406$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fppul.20406$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17817161$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16617451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dohna-Schwake, Christian</creatorcontrib><creatorcontrib>Ragette, Regine</creatorcontrib><creatorcontrib>Teschler, Helmut</creatorcontrib><creatorcontrib>Voit, Thomas</creatorcontrib><creatorcontrib>Mellies, Uwe</creatorcontrib><title>IPPB-assisted coughing in neuromuscular disorders</title><title>Pediatric pulmonology</title><addtitle>Pediatr. Pulmonol</addtitle><description>In neuromuscular disorders, reduced peak cough flows (PCFs) are considered to increase the risk of respiratory complications such as pneumonia or chronic atelectasis. Different methods were described to improve PCF. However, these studies were primarily carried out in adults, and there is limited information regarding the use and efficacy of these methods in children with respiratory muscle weakness. The aim of this study was to investigate whether hyperinsufflation with an intermittent positive‐pressure breathing (IPPB) device is effective in cough augmentation in pediatric patients. Spirometry (forced inspiratory vital capacity, FIVC; forced expiratory volume in 1 sec, FEV1), respiratory muscle pressures (peak inspiratory pressure, PIP; peak expiratory pressure, PEP), and PCF were measured in 29 schoolchildren with various neuromuscular disorders. IPPB‐assisted hyperinsufflation was taught individually to increase lung volumes (maximum insufflation capacity, MIC) above FIVC. The impact of hyperinsufflation on peak cough flow was documented. In 28/29 patients, IPPB‐assisted hyperinsufflation enhanced FIVC from 0.68 ± 0.40 l to an MIC of 1.05 ± 0.47 l (P &lt; 0.001). Unassisted PCF was 119.0 ± 57.7 l/min, and increased to 194.5 ± 74.9 l/min (P &lt; 0.001) in 27/29 patients. This effect was similar in young patients (ages 6–10 years) and older patients (aged &gt;10 years). Augmentation of lung volumes from FIVC to MIC correlated with an increase of PCF (R = 0.42, P &lt; 0.05). IPPB‐assisted hyperinsufflation improves PCF in pediatric neuromuscular disorders. The results suggest that this technique can be used to improve clearance of airway secretions and therefore reduce respiratory morbidity in children with NMD. Pediatr Pulmonol. © 2006 Wiley‐Liss, Inc.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>assisted coughing</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Cough - etiology</subject><subject>Cough - therapy</subject><subject>Female</subject><subject>Forced Expiratory Volume - physiology</subject><subject>Humans</subject><subject>Intermittent Positive-Pressure Breathing - methods</subject><subject>Male</subject><subject>maximum insufflation capacity</subject><subject>Medical sciences</subject><subject>Muscle Weakness - physiopathology</subject><subject>Muscular Atrophy, Spinal - complications</subject><subject>Muscular Atrophy, Spinal - physiopathology</subject><subject>Muscular Dystrophies - complications</subject><subject>Muscular Dystrophies - congenital</subject><subject>Muscular Dystrophies - physiopathology</subject><subject>Muscular Dystrophy, Duchenne - complications</subject><subject>Muscular Dystrophy, Duchenne - physiopathology</subject><subject>Neuromuscular Diseases - complications</subject><subject>Neuromuscular Diseases - physiopathology</subject><subject>neuromuscular disorders</subject><subject>peak cough flow</subject><subject>Pneumology</subject><subject>Pulmonary Ventilation - physiology</subject><subject>Respiration Disorders - etiology</subject><subject>Respiration Disorders - therapy</subject><subject>Respiratory Function Tests</subject><subject>respiratory muscle weakness</subject><subject>Respiratory Muscles - physiopathology</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Respiratory Therapy - instrumentation</subject><subject>Respiratory Therapy - methods</subject><subject>Spirometry</subject><subject>Treatment Outcome</subject><subject>Vital Capacity - physiology</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EgvKx8ANQFxiQAj7bOScjRVBAFVQCxGi59gUCaVJsIuDfk9ICG9MN97zv6R7GdoEfAefieDZrqyPBFccV1gOe5wlXOa6yXqbTNMEM5QbbjPGZ826XwzrbAETQKoUeg8vxeJDYGMv4Rr7vmvbxqawf-2Xdr6kNzbSNrq1s6PsyNsFTiNtsrbBVpJ3l3GL352d3pxfJ6GZ4eXoySpxCwIS8VwVRzklIL4TjPnUFClVYjxPEAjIpJZJS6YS0zAovMuCWC7SgCLWWW-xg0TsLzWtL8c1My-ioqmxNTRsN6lwokecdeLgAXWhiDFSYWSinNnwa4GYuyMwFmW9BHby3bG0nU_J_6NJIB-wvARudrYpga1fGP05noAHnHCy497Kiz39OmvH4fvRzPFlk5rI_fjM2vHTfSJ2ah-uh4VfiDmFwa4byCxzBi-E</recordid><startdate>200606</startdate><enddate>200606</enddate><creator>Dohna-Schwake, Christian</creator><creator>Ragette, Regine</creator><creator>Teschler, Helmut</creator><creator>Voit, Thomas</creator><creator>Mellies, Uwe</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200606</creationdate><title>IPPB-assisted coughing in neuromuscular disorders</title><author>Dohna-Schwake, Christian ; Ragette, Regine ; Teschler, Helmut ; Voit, Thomas ; Mellies, Uwe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4616-edd4fee90e23d22c0d5cf624fad6b66f183336e445be738fd2810a026a14e6773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>assisted coughing</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Cough - etiology</topic><topic>Cough - therapy</topic><topic>Female</topic><topic>Forced Expiratory Volume - physiology</topic><topic>Humans</topic><topic>Intermittent Positive-Pressure Breathing - methods</topic><topic>Male</topic><topic>maximum insufflation capacity</topic><topic>Medical sciences</topic><topic>Muscle Weakness - physiopathology</topic><topic>Muscular Atrophy, Spinal - complications</topic><topic>Muscular Atrophy, Spinal - physiopathology</topic><topic>Muscular Dystrophies - complications</topic><topic>Muscular Dystrophies - congenital</topic><topic>Muscular Dystrophies - physiopathology</topic><topic>Muscular Dystrophy, Duchenne - complications</topic><topic>Muscular Dystrophy, Duchenne - physiopathology</topic><topic>Neuromuscular Diseases - complications</topic><topic>Neuromuscular Diseases - physiopathology</topic><topic>neuromuscular disorders</topic><topic>peak cough flow</topic><topic>Pneumology</topic><topic>Pulmonary Ventilation - physiology</topic><topic>Respiration Disorders - etiology</topic><topic>Respiration Disorders - therapy</topic><topic>Respiratory Function Tests</topic><topic>respiratory muscle weakness</topic><topic>Respiratory Muscles - physiopathology</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Respiratory Therapy - instrumentation</topic><topic>Respiratory Therapy - methods</topic><topic>Spirometry</topic><topic>Treatment Outcome</topic><topic>Vital Capacity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dohna-Schwake, Christian</creatorcontrib><creatorcontrib>Ragette, Regine</creatorcontrib><creatorcontrib>Teschler, Helmut</creatorcontrib><creatorcontrib>Voit, Thomas</creatorcontrib><creatorcontrib>Mellies, Uwe</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dohna-Schwake, Christian</au><au>Ragette, Regine</au><au>Teschler, Helmut</au><au>Voit, Thomas</au><au>Mellies, Uwe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IPPB-assisted coughing in neuromuscular disorders</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr. Pulmonol</addtitle><date>2006-06</date><risdate>2006</risdate><volume>41</volume><issue>6</issue><spage>551</spage><epage>557</epage><pages>551-557</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><coden>PEPUES</coden><abstract>In neuromuscular disorders, reduced peak cough flows (PCFs) are considered to increase the risk of respiratory complications such as pneumonia or chronic atelectasis. Different methods were described to improve PCF. However, these studies were primarily carried out in adults, and there is limited information regarding the use and efficacy of these methods in children with respiratory muscle weakness. The aim of this study was to investigate whether hyperinsufflation with an intermittent positive‐pressure breathing (IPPB) device is effective in cough augmentation in pediatric patients. Spirometry (forced inspiratory vital capacity, FIVC; forced expiratory volume in 1 sec, FEV1), respiratory muscle pressures (peak inspiratory pressure, PIP; peak expiratory pressure, PEP), and PCF were measured in 29 schoolchildren with various neuromuscular disorders. IPPB‐assisted hyperinsufflation was taught individually to increase lung volumes (maximum insufflation capacity, MIC) above FIVC. The impact of hyperinsufflation on peak cough flow was documented. In 28/29 patients, IPPB‐assisted hyperinsufflation enhanced FIVC from 0.68 ± 0.40 l to an MIC of 1.05 ± 0.47 l (P &lt; 0.001). Unassisted PCF was 119.0 ± 57.7 l/min, and increased to 194.5 ± 74.9 l/min (P &lt; 0.001) in 27/29 patients. This effect was similar in young patients (ages 6–10 years) and older patients (aged &gt;10 years). Augmentation of lung volumes from FIVC to MIC correlated with an increase of PCF (R = 0.42, P &lt; 0.05). IPPB‐assisted hyperinsufflation improves PCF in pediatric neuromuscular disorders. The results suggest that this technique can be used to improve clearance of airway secretions and therefore reduce respiratory morbidity in children with NMD. Pediatr Pulmonol. © 2006 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16617451</pmid><doi>10.1002/ppul.20406</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 8755-6863
ispartof Pediatric pulmonology, 2006-06, Vol.41 (6), p.551-557
issn 8755-6863
1099-0496
language eng
recordid cdi_proquest_miscellaneous_67924299
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
Age Factors
assisted coughing
Biological and medical sciences
Child
Cough - etiology
Cough - therapy
Female
Forced Expiratory Volume - physiology
Humans
Intermittent Positive-Pressure Breathing - methods
Male
maximum insufflation capacity
Medical sciences
Muscle Weakness - physiopathology
Muscular Atrophy, Spinal - complications
Muscular Atrophy, Spinal - physiopathology
Muscular Dystrophies - complications
Muscular Dystrophies - congenital
Muscular Dystrophies - physiopathology
Muscular Dystrophy, Duchenne - complications
Muscular Dystrophy, Duchenne - physiopathology
Neuromuscular Diseases - complications
Neuromuscular Diseases - physiopathology
neuromuscular disorders
peak cough flow
Pneumology
Pulmonary Ventilation - physiology
Respiration Disorders - etiology
Respiration Disorders - therapy
Respiratory Function Tests
respiratory muscle weakness
Respiratory Muscles - physiopathology
Respiratory system : syndromes and miscellaneous diseases
Respiratory Therapy - instrumentation
Respiratory Therapy - methods
Spirometry
Treatment Outcome
Vital Capacity - physiology
title IPPB-assisted coughing in neuromuscular disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A47%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IPPB-assisted%20coughing%20in%20neuromuscular%20disorders&rft.jtitle=Pediatric%20pulmonology&rft.au=Dohna-Schwake,%20Christian&rft.date=2006-06&rft.volume=41&rft.issue=6&rft.spage=551&rft.epage=557&rft.pages=551-557&rft.issn=8755-6863&rft.eissn=1099-0496&rft.coden=PEPUES&rft_id=info:doi/10.1002/ppul.20406&rft_dat=%3Cproquest_cross%3E67924299%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67924299&rft_id=info:pmid/16617451&rfr_iscdi=true